Evidence map›Paper›PMID 39452199›Full record

ArticleAntibiotics (Basel, Switzerland)2024

Genetic Determinants of Clarithromycin and Fluoroquinolones Resistance in

Dusan Kekic, Milos Jovicevic, Jovana Kabic, Iva Lolic, Ina Gajic, Stefan Stojkovic, Lazar Ranin, Tomica Milosavljevic, Natasa Opavski, Ivan Rankovic and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Dusan KekicInstitute for Microbiology and Immunology, Faculty of Medicine, University of Belgrade, 11 000 Belgrade, Serbia.ORCID 0000-0002-0327-4838
Milos JovicevicInstitute for Microbiology and Immunology, Faculty of Medicine, University of Belgrade, 11 000 Belgrade, Serbia.
Jovana KabicInstitute for Microbiology and Immunology, Faculty of Medicine, University of Belgrade, 11 000 Belgrade, Serbia.ORCID 0000-0002-3727-6583
Iva LolicEmergency Center, University Clinical Center of Serbia, 11 000 Belgrade, Serbia.ORCID 0000-0001-7565-4584
Ina GajicInstitute for Microbiology and Immunology, Faculty of Medicine, University of Belgrade, 11 000 Belgrade, Serbia.ORCID 0000-0002-1578-2776
Stefan StojkovicClinic for Gastroenterology and Hepatology, University Clinical Centre of Serbia, 11 000 Belgrade, Serbia.ORCID 0000-0002-2256-7513
Lazar RaninInstitute for Microbiology and Immunology, Faculty of Medicine, University of Belgrade, 11 000 Belgrade, Serbia.
Tomica MilosavljevicEuromedic, General Hospital, 11 000 Belgrade, Serbia.ORCID 0000-0002-4396-7532
Natasa OpavskiInstitute for Microbiology and Immunology, Faculty of Medicine, University of Belgrade, 11 000 Belgrade, Serbia.ORCID 0000-0002-8765-4044
Ivan RankovicDepartment of Gastroenterology and Liver Care, Royal Cornwall Hospitals NHS Trust University of Exeter, Treliske, Truro, Cornwall TR1 3LQ, UK.ORCID 0000-0002-5767-3914
Vladimir MilivojevicClinic for Gastroenterology and Hepatology, University Clinical Centre of Serbia, 11 000 Belgrade, Serbia.ORCID 0000-0003-3601-7528

Funding

Ministry of Science, Technological Development and Innovation of the Republic of Serbia 451-03-66/2024-03/200110
6 · The paper itself

Abstract

BACKGROUND/

objectivesStomach infections by

methodsStomach biopsies from symptomatic patients were subjected to molecular testing by GenoType Helico DR kit (Hain Lifescience GmbH, Nehren, Germany).

resultsPositive findings on the presence of

conclusionsResults indicate the need for the implementation of the latest Maastricht VI Consensus recommendations for both AST whenever possible and the use of tailored guided therapy options due to high resistance rates and possible treatment failures. The GenoType Helico DR kit is a useful tool for AST, especially in cases of mixed

Indexed as

antibiotic resistanceclarithromycinfluoroquinolonesgenetic determinantsHelicobacter pyloriSerbia

Identifiers

PMID39452199
PMCPMC11505191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.